Cost-effectiveness of a fixed-dose combination of solifenacin and oral controlled adsorption system formulation of tamsulosin in men with lower urinary tract symptoms associated with benign prostatic hyperplasia
Crossref DOI link: https://doi.org/10.1186/s12894-015-0031-8
Published Online: 2015-05-09
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nazir, Jameel
Heemstra, Lars
van Engen, Anke
Hakimi, Zalmai
Ivanescu, Cristina
License valid from 2015-05-09
Article History
Received: 14 November 2014
Accepted: 16 April 2015
First Online: 9 May 2015